Jackson Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,749
Closed -$1.49M 161
2024
Q2
$1.49M Sell
2,749
-2,130
-44% -$1.13M 0.32% 63
2024
Q1
$2.53M Buy
4,879
+136
+3% +$67.6K 0.32% 62
2023
Q4
$2.24M Sell
4,743
-97
-2% -$44.9K 0.29% 64
2023
Q3
$2.11M Sell
4,840
-468
-9% -$212K 0.3% 63
2023
Q2
$2.36M Sell
5,308
-83
-2% -$38.3K 0.35% 59
2023
Q1
$2.48M Buy
5,391
+93
+2% +$44.3K 1.86% 12
2022
Q4
$2.72M Buy
5,298
+519
+11% +$264K 1% 34
2022
Q3
$2.17M Buy
4,779
+2,875
+151% +$1.38M 0.43% 53
2022
Q2
$919K Sell
1,904
-2,737
-59% -$1.35M 0.43% 54
2022
Q1
$2.28M Sell
4,641
-107
-2% -$48.9K 0.32% 74
2021
Q4
$2.2M Buy
+4,748
New +$2M 0.28% 81
2021
Q3
Sell
-4,711
Closed -$1.8M 98
2021
Q2
$1.8M Sell
4,711
-173
-4% -$66.1K 0.23% 87
2021
Q1
$1.75M Sell
4,884
-180
-4% -$57.9K 0.26% 87
2020
Q4
$1.63M Buy
5,064
+675
+15% +$207K 0.22% 91
2020
Q3
$1.18M Buy
4,389
+483
+12% +$130K 0.18% 95
2020
Q2
$1.03M Buy
+3,906
New +$1.04M 0.18% 98

Other funds holding ELV

Jackson Wealth Management's ELV Position: Q3 2024 in Review

Jackson Wealth Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 2,749 shares — an estimated $1.49M sold.

Jackson Wealth Management first reported a position in ELV in Q2 2020 and held it in 16 quarters. The position peaked at $2.72M in Q4 2022. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Jackson Wealth Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Jackson Wealth Management sold 2,749 Elevance Health shares in Q3 2024, an estimated $1.49M.
  • Jackson Wealth Management first reported a position in Elevance Health in Q2 2020 and held it in 16 quarters.
  • Jackson Wealth Management's Elevance Health position peaked at $2.72M in Q4 2022.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Jackson Wealth Management's 13F filing for Q3 2024, filed 22 Oct 2024.